These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30790269)

  • 1. Will converting naloxone to over-the-counter status increase pharmacy sales?
    Murphy SM; Morgan JR; Jeng PJ; Schackman BR
    Health Serv Res; 2019 Aug; 54(4):764-772. PubMed ID: 30790269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community pharmacy naloxone supply, before and after rescheduling as an over-the-counter drug: sales and prescriptions data, 2014-2018.
    Tse WC; Sanfilippo P; Lam T; Dietze P; Nielsen S
    Med J Aust; 2020 Apr; 212(7):314-320. PubMed ID: 32124984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone Availability and Cost After Transition to an Over-the-Counter Product.
    Marley GT; Annis IE; Egan KL; Delamater P; Carpenter DM
    JAMA Health Forum; 2024 Jul; 5(7):e241920. PubMed ID: 39058509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017.
    Guadamuz JS; Alexander GC; Chaudhri T; Trotzky-Sirr R; Qato DM
    JAMA Netw Open; 2019 Jun; 2(6):e195388. PubMed ID: 31173125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.
    Graves RL; Andreyeva E; Perrone J; Shofer FS; Merchant RM; Meisel ZF
    J Addict Med; 2019; 13(4):272-278. PubMed ID: 30585876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.
    Stopka TJ; Donahue A; Hutcheson M; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S34-S44. PubMed ID: 28189540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire.
    Bolivar D; Hartung D; Silcox J; Bratberg J; Boggis J; Rabin M; Green TC
    J Am Pharm Assoc (2003); 2023; 63(1):330-335.e1. PubMed ID: 36369076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rurality and differences in pharmacy characteristics and community factors associated with provision of naloxone in the pharmacy.
    Green TC; Bratberg J; Baird J; Burstein D; Lenz K; Case P; Walley AY; Xuan Z
    Int J Drug Policy; 2020 Nov; 85():102602. PubMed ID: 31740174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Naloxone by Payer Type.
    Jiang X; Strahan AE; Zhang K; Guy GP
    JAMA; 2024 Feb; 331(8):700-702. PubMed ID: 38285437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources-Rhode Island, Massachusetts, and New York City, 2013-2019.
    Chatterjee A; Yan S; Lambert A; Morgan JR; Green TC; Jeng PJ; Jalali A; Xuan Z; Krieger M; Marshall BDL; Walley AY; Murphy SM
    Health Serv Res; 2023 Oct; 58(5):1141-1150. PubMed ID: 37408299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-the-counter sales of antibiotics from community pharmacies in Abu Dhabi.
    Dameh M; Green J; Norris P
    Pharm World Sci; 2010 Oct; 32(5):643-50. PubMed ID: 20640511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone Accessibility by Standing Order in North Carolina Community Pharmacies.
    Marley G; Annis IE; Ostrach B; Egan K; Delamater PL; Bell R; Dasgupta N; Carpenter DM
    J Am Pharm Assoc (2003); 2024; 64(3):102021. PubMed ID: 38307248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxone Dispensing to Youth Ages 10-19: 2017-2022.
    Terranella A; Guy G; Mikosz C
    Pediatrics; 2024 Oct; 154(4):. PubMed ID: 39262344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
    Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
    Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vital Signs: Pharmacy-Based Naloxone Dispensing - United States, 2012-2018.
    Guy GP; Haegerich TM; Evans ME; Losby JL; Young R; Jones CM
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(31):679-686. PubMed ID: 31393863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes towards sales and use of over-the-counter drugs in Sweden in a reregulated pharmacy market: a population-based study.
    Hedenrud T; Andersson Sundell K; Martinsson J; Håkonsen H
    Int J Pharm Pract; 2019 Feb; 27(1):17-24. PubMed ID: 29687513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of prescription and over-the-counter supply of ophthalmic chloramphenicol in Wales in the 5 years following reclassification.
    Du HC; John DN; Walker R
    Int J Pharm Pract; 2014 Feb; 22(1):20-7. PubMed ID: 23590558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting bargaining outcomes between pharmacies and insurers.
    Brooks JM; Doucette W; Sorofman B
    Health Serv Res; 1999 Apr; 34(1 Pt 2):439-51. PubMed ID: 10199687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacist knowledge, attitudes and confidence regarding naloxone for overdose reversal.
    Nielsen S; Menon N; Larney S; Farrell M; Degenhardt L
    Addiction; 2016 Dec; 111(12):2177-2186. PubMed ID: 27367125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.